688323.SH
瑞华泰
SSE · Basic Materials · Chemicals - Specialty · CN
CNY 26.95
−8.15%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 399.3M | 386.7M | 339.1M | 275.9M | 301.7M |
| Cost of Revenue | 329.1M | 316.1M | 274.6M | 202.6M | 186.1M |
| Gross Profit | 70.2M | 70.7M | 64.4M | 73.3M | 115.6M |
| Operating Expenses | |||||
| R&D Expense | 38.4M | 38.3M | 33.7M | 32.2M | 27.0M |
| SG&A Expense | — | — | — | — | — |
| General & Admin Expense | 54.6M | 55.2M | 46.6M | 36.3M | 37.6M |
| Selling & Marketing Expense | 8.7M | 8.1M | 6.7M | 6.4M | 6.2M |
| Other Expenses | — | — | — | — | — |
| Total Operating Expenses | 166.3M | 163.2M | 129.2M | 97.7M | 86.9M |
| Cost and Expenses | 495.4M | 479.2M | 403.8M | 300.4M | 272.9M |
| Operating Income (EBIT) | (103.3M) | (98.4M) | (62.6M) | (20.7M) | 39.4M |
| Non-Operating | |||||
| Interest Income | — | — | — | — | — |
| Interest Expense | — | — | — | — | — |
| Net Interest Income | — | — | — | — | — |
| Other Non-Op Income/Expense | — | — | — | — | — |
| Non-Operating Income (excl Interest) | — | — | — | — | — |
| EBT (Pre-Tax Income) | (104.2M) | (99.7M) | (63.6M) | (20.8M) | 40.4M |
| Income Tax Expense | (7.7M) | (7.4M) | (6.3M) | (1.2M) | 1.5M |
| Bottom Line | |||||
| Net Income | (96.6M) | (92.3M) | (57.3M) | (19.6M) | 38.9M |
| Earnings from Cont. Ops | (96.6M) | (92.3M) | (57.3M) | (19.6M) | 38.9M |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (96.6M) | (92.3M) | (57.3M) | (19.6M) | 38.9M |
| Per Share | |||||
| Basic EPS | (CN¥0.54) | (CN¥0.51) | (CN¥0.32) | (CN¥0.11) | CN¥0.22 |
| Diluted EPS | (CN¥0.54) | (CN¥0.51) | (CN¥0.32) | (CN¥0.11) | CN¥0.22 |
| Revenue Per Share | CN¥2.29 | CN¥2.14 | CN¥1.89 | CN¥1.55 | CN¥1.71 |
| Shares | |||||
| Basic Shares Outstanding | 174.1M | 181.1M | 179.0M | 178.2M | 176.7M |
| Diluted Shares Outstanding | 174.1M | 181.1M | 179.0M | 178.2M | 176.7M |
| Profitability Metrics | |||||
| EBITDA | — | 41.3M | 37.7M | 43.4M | 93.2M |
| D&A | — | 139.8M | 100.3M | 64.0M | 53.8M |
| EBIT | — | — | — | — | — |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026